Cell-Easy provides quick and easy access to ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects.
Employees: 11-50
Founded date: 2018
Investors 3
| Date | Name | Website |
| - | Merieux De... | merieux-pa... |
| - | M Capital ... | mcapital.f... |
| - | Korys | korys.be |
Mentions in press and media 1
| Date | Title | Description |
| 22.06.2023 | IUCT-Oncopole and Cell-Easy sign a MOU to accelerate cancer patient access to advanced cell-based therapy | IUCT-Oncopole and Cell-Easy announced the signing of a MOU to enhance their strategic collaborative relationship and access to advanced cell-based therapies. This partnership will benefit cancer patients as it will streamline the clinical t... |